Title : Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism.

Pub. Date : 2020 Nov 17

PMID : 33245718






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Mubritinib was originally identified as a receptor tyrosine kinase (RTK) inhibitor selective for HER2/ErbB2. TAK-165 erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Mubritinib was originally identified as a receptor tyrosine kinase (RTK) inhibitor selective for HER2/ErbB2. TAK-165 erb-b2 receptor tyrosine kinase 2 Homo sapiens